Preview

Российский кардиологический журнал

Расширенный поиск

РОЛЬ ДЕФИЦИТА МАГНИЯ В ПАТОГЕНЕЗЕ СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ: СОВРЕМЕННОЕ СОСТОЯНИЕ ПРОБЛЕМЫ

https://doi.org/10.15829/1560-4071-2017-6-167-172

Полный текст:

Аннотация

В обзоре представлены данные о влиянии дефицита магния на компоненты патогенеза сердечно-сосудистых заболеваний. Особое внимание отдавалось его роли в регуляции сосудистого тонуса, эндотелиальной функции, процессов атерогенеза и атеротромбоза, а также функции проводящей системы сердца, нарушение которых обусловливает инициацию и прогрессирование таких заболеваний, как эссенциальная гипертензия, хроническая сердечная недостаточность и ишемическая болезнь сердца. Также были систематизированы данные о роли коррекции гомеостаза данного элемента в профилактике и лечении данных патологий.

Об авторах

Д. Э. Майлян
Донецкий национальный медицинский университет им. М. Горького
Украина
Ассистент кафедры внутренних болезней, SPIN-код: 3757-9505


В. В. Коломиец
Донецкий национальный медицинский университет им. М. Горького
Украина
Зав. кафедрой внутренних болезней, д.м.н., профессор, SPIN-код: 1971-0071


Список литературы

1. Russia in figures. 2016: Statistical handbook. Moscow: Rosstat, 2016. p. 545. Russian (Россия в цифрах. 2016: Краткий статистический сборник. Москва: Росстат, 2016. 545 c.)

2. Starostin I.V. Place of Magnesium Salts in the Treatment of Cardiovascular Disease. Cardiology 2012; 52(8): 83-8. Russian (Старостин И.В. Место магния в терапии сердечно-сосудистых заболеваний. Кардиология 2012; 52(8): 83-8).

3. Gröber U, Schmidt J, Kisters K. Magnesium in Prevention and Therapy. Nutrients 2015; 7(9): 8199–226.

4. Nielsen FH, Johnson LA. Data from Controlled Metabolic Ward Studies Provide Guidance for the Determination of Status Indicators and Dietary Requirements for Magnesium. Biol Trace Elem Res. 2016; published online 24 Oct 2016. http://link.springer.com/article/10.1007%2Fs12011-016-0873-2. DOI: 10.1007/s12011-016-0873-2.

5. Jahnen-Dechent J, Ketteler M. Magnesium basics. Clin Kidney J 2012; 5: 3–14.

6. Gröber U. Magnesium. In Micronutrients: Metabolic Tuning-Prevention-Therapy, 1st ed. Stuttgart, Germany: MedPharm Scientific Publishers, 2009: 159-66.

7. Cohen L. Physiologic assessment of magnesium status in humans: a combination of load retention and renal excretion. IMAJ 2006; 2: 938-9.

8. Gröber U. Interactions between drugs and micronutrients. Med Monatsschr Pharm 2006; 29: 26–35.

9. Gromova OA, Torshin IYu, Yudina NV et al. Magnesium Deficiency and Dysregulation of Vascular Tone. Cardiology 2014; 7: 66-72. Russian (Громова О.А., Торшин И.Ю., Юдина Н.В. и др. Дефицит магния и нарушения регуляции тонуса сосудов. Кардиология. 2014; 7: 66-72).

10. Fatih Kircelli, Mirjam E. Peter, Ebru Sevinc Ok, et al. Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner. Nephrol Dial Transplant 2012; 27(2): 514–21.

11. Montes AO, Guerrero F, Martinez-Moreno JM et al. Magnesium Inhibits Wnt/β-Catenin Activity and Reverses the Osteogenic Transformation of Vascular Smooth Muscle Cells. PLoS One 2014; 9(2): e89525.

12. Monalisa Das, Patralekha Ray Chaudhuri, Badal C. Mondal, Sukumar Mitra, Debasmita Bandyopadhyay, Sushobhan Pramanik Assessment of serum magnesium levels and its outcome in neonates of eclamptic mothers treated with low-dose magnesium sulfate regimen Indian J Pharmacol 2015; 47(5): 502–508.

13. Shechter M, Bairey Merz CN, Stuehlinger HG et al. Oral magnesium supplementation improves exercise duration and quality of life in patients with coronary artery disease. Am J Cardiol 2003; 91: 517-21.

14. Pokan R, Hofmann P, von Duvillard SP et al. Oral magnesium therapy, exercise heart rate, exercise tolerance, and myocardial function in coronary artery disease patients. Br J Sports Med. 2006; 40: 773-8.

15. Lerman A, Zeiher AM. Endothelial function cardiac events. Circulation 2005; 111: 363-8.

16. Shechter M, Sherer Y. Endothelial dysfunction: a crystal ball prediction for enhanced cardiovascular risk? Isr Med Assoc J 2003; 5: 736-8.

17. Paravicini TM, Yogi A, Mazur A, Touyz RM. Dysregulation of vascular TRPM7 and annexin-1 is associated with endothelial dysfunction in inherited hypomagnesemia. Hypertension 2009; 53: 423-9.

18. Song Y, Li TY, van Dam RM, et al. Magnesium intake and plasma concentrations of markers of systemic inflammation and endothelial dysfunction in women. Am J Clin Nutr. 2007; 85: 1068-74.

19. Chacko SA, Song Y, Nathan L et al. Relations of dietary magnesium intake to biomarkers of inflammation and endothelial dysfunction in an ethnically diverse cohort of postmenopausal women. Diabetes Care 2010; 33: 304-10.

20. Kieboom BC, Niemeijer MN, Leening MG et al. Hoorn serum magnesium and the risk of death from coronary heart disease and sudden cardiac death. J Am Heart Assoc 2016; 5(1): e002707.

21. Amighi J, Sabeti S, Schlager O et al. Low serum magnesium predicts neurological events in patients with advanced atherosclerosis. Stroke 2004; 35: 22-7.

22. Pachikian BD, Neyrinck AM, Deldicque L et al. Changes in intestinal bifidobacteria levels are associated with the inflammatory response in magnesium-deficient mice. J Nutr 2010; 140: 509-14.

23. Lin CY, Tsai PS, Hung YC, Huang CJ. L-type calciumchannels are involved in mediating the anti-inflammatory effects of magnesium sulphate. Br J Anaesth 2010; 104: 44-51.

24. King DE. Inflammation and elevation of C-reactive protein: does magnesium play a key role? Magnes Res 2009; 22: 57-9.

25. Kieboom BC, Niemeijer MN, Leening MG et al. Hoorn Inadequate dietary magnesium intake increases atherosclerotic plaque development in rabbits. J Am Heart Assoc 2016; 5(1): e002707.

26. Fu ZY, Yang FL, Hsu HW, Lu YF. Drinking deep seawater decreases serum total and low-density lipoprotein–cholesterol in hypercholesterolemic subjects. J Med Food 2012; 15(6): 535–41.

27. Chen Y, Wang X, Shen Z et al. Effects of dietary components on high-density lipoprotein measures in a cohort of 1,566 participants. Lipids Health Dis. 2015; 20: 14-34.

28. Corretti MC, Anderson TJ, Benjamin EJ, et al. International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilatation of the brachial artery. J Am Coll Cardiol 2002; 39: 257-65.

29. Rukshin V, Shah PK, Cercek B et al. Comparative antithrombotic effects of magnesium sulfate and platelet glycoprotein IIb/IIIa inhibitors tirofiban and eptifibatide in a canine model of stent thrombosis. Circulation 2002; 105: 1970-5.

30. An G, Du Z, Meng X et al. Association between low serum magnesium level and major adverse cardiac events in patients treated with drug-eluting stents for acute myocardial infarction. PLoS One 2014; 9(6): e98971.

31. Vierling W, Liebscher DH, Micke O et al. Magnesium deficiency and therapy in cardiac arrhythmias: Recommendations of the German Society for Magnesium Research. Deutsch. Med. Wochenschr 2013; 138: 1165–71.

32. Elin RJ. Assessment of magnesium status for diagnosis and therapy. Magnes Res 2010; 23: 194–8.

33. Gao X, Peng L, Adhikari CM et al. Spironolactone reduced arrhythmia and maintained magnesium homeostasis in patients with congestive heart failure. J Card Fail 2007; 13: 170–7.

34. Povoroznyuk V.V., Snezhitskiy V.A., Yankouskaya L.V. et al. Extraskeletal effects of vitamin D: role in the pathogenesis of cardiovascular diseases. Journal of the Grodno State Medical University 2015; 2(50): 6-15. Russian (Поворознюк В.В., Снежицкий В.А., Янковская Л.В. и др. Значение витамина D в патогенезе сердечно-сосудистых заболеваний. Журнал Гродненского государственного медицинского университета 2015; 2(50): 6-15.)

35. Rosanoff А, Dai Qi, Shapses SA Essential Nutrient Interactions: Does Low or Suboptimal Magnesium Status Interact with Vitamin D and/or Calcium Status? American Society for Nutrition. Adv Nutr 2016; 7: 25–43.

36. Shah NC, Shah JG, Li Z et al. Short-term magnesium deficiency downregulates telomerase, upregulates neutral sphingomyelinase and induces oxidative DNA damage in cardiovascular tissues: relevance to atherogenesis, cardiovascular diseases and aging. Int. J. Clin. Exp. Med. 2014; 7: 497–514.

37. Shechter M, Shechter A. Magnesium and myocardial infarction. Clin Calcium 2005; 11: 111-5.

38. Kolomiyets V.V., Mailian D.E., Tretyak L.A. et al. Influence of renal calcium and magnesium egestion optimization on diuretics antihypertensive and cardioprotective properties. Belgorod State University Scientific Bulletin Medicine Pharmacy 2015; 10(207): 63-9. Russian (Коломиец В.В., Майлян Д.Э., Третяк Л.А. и др. Влияние оптимизации почечной экскреции кальция и магния на антигипертензивные и кардиопротекторные свойства диуретиков. Научные ведомости Белгородского государственного университета. Серия: Медицина. Фармация 2015; 10(207): 63-9).

39. Adamopoulos C, Pitt B, Sui X et al. Low serum magnesium and cardiovascular mortality in chronic heart failure: A propensitymatched study. Intern J Cardio 2009; 136: 270-7.

40. Stepura OB, Martynow AI. Magnesium orotate in severe congestive heart failure (MACH). Intern J Cardiol 2009; 131: 293-5.

41. Kisters K, Gremmler B, Gröber U. Natriuretic peptides, hypertension, heart insufficiency and magnesium. Adv Tech Biol Med 2015; 3: 134.

42. Kisters K, Gremmler B, Gröber U. Magnesium deficiency in hypertensive heart disease. J Hypertens 2015; 33: e273.


Для цитирования:


Майлян Д.Э., Коломиец В.В. РОЛЬ ДЕФИЦИТА МАГНИЯ В ПАТОГЕНЕЗЕ СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ: СОВРЕМЕННОЕ СОСТОЯНИЕ ПРОБЛЕМЫ. Российский кардиологический журнал. 2017;(6):167-172. https://doi.org/10.15829/1560-4071-2017-6-167-172

For citation:


Maylian D.E., Kolomiets V.V. MAGNESIUM DEFICIENCY IN PATHOGENESIS OF CARDIOVASCULAR DISEASES: RECENT DEVELOPMENTS. Russian Journal of Cardiology. 2017;(6):167-172. (In Russ.) https://doi.org/10.15829/1560-4071-2017-6-167-172

Просмотров: 195


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1560-4071 (Print)
ISSN 2618-7620 (Online)